Results for "lung transplantation."
Pulmonary Fibrosis
Pulmonary fibrosis is a chronic and progressive lung disease characterized by scarring and thickening of lung tissue, leading to impaired lung function and potentially life-threatening complications. ## Overview Pulmonary fibrosis is a group of diseases that cause scarring and thickening of lung tissue, leading to impaired lung function and shortness of breath. The scarring can be caused by various factors, including exposure to certain chemicals, infections, and autoimmune disorders. The disease can be idiopathic, meaning its cause is unknown, or it can be secondary to another condition. The symptoms of pulmonary fibrosis can vary in severity and may include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. As the disease progresses, it can lead to complications such as pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer. The scarring in pulmonary fibrosis can be diffuse, affecting the entire lung, or it can be localized to specific areas. The scarring can also be interstitial, affecting the spaces around the air sacs in the lungs, or it can be bronchiolar, affecting the small airways. The disease can be diagnosed using imaging tests such as high-resolution computed tomography (HRCT) and pulmonary function tests (PFTs). There is currently no cure for pulmonary fibrosis, but treatment options are available to manage symptoms and slow disease progression. ## History/Background The term "pulmonary fibrosis" was first used in the late 19th century to describe a condition characterized by scarring and thickening of lung tissue. However, the disease has been described in medical literature for centuries. In the early 20th century, the disease was often referred to as "idiopathic pulmonary fibrosis" (IPF), which is still a common term used today. The exact cause of IPF is still unknown, but it is believed to be related to genetic and environmental factors. In the 1950s and 1960s, the disease was often treated with corticosteroids and other immunosuppressive medications. However, these treatments were often ineffective and had significant side effects. In the 1980s and 1990s, the development of new medications, such as pirfenidone and nintedanib, provided new treatment options for patients with pulmonary fibrosis. These medications have been shown to slow disease progression and improve symptoms in some patients. ## Key Information **Causes and Risk Factors** Pulmonary fibrosis can be caused by various factors, including: * Exposure to certain chemicals, such as asbestos and silica * Infections, such as pneumonia and tuberculosis * Autoimmune disorders, such as rheumatoid arthritis and lupus * Genetic disorders, such as alpha-1 antitrypsin deficiency * Radiation therapy to the chest * Certain medications, such as amiodarone and bleomycin **Symptoms** The symptoms of pulmonary fibrosis can vary in severity and may include: * Shortness of breath * Dry cough * Feeling tired * Weight loss * Nail clubbing **Complications** Pulmonary fibrosis can lead to various complications, including: * Pulmonary hypertension * Respiratory failure * Pneumothorax * Lung cancer **Diagnosis** Pulmonary fibrosis can be diagnosed using imaging tests such as HRCT and PFTs. A diagnosis of pulmonary fibrosis is often made based on a combination of these tests and a thorough medical history. ## Significance Pulmonary fibrosis is a serious and potentially life-threatening disease that affects millions of people worldwide. The disease can have a significant impact on a person's quality of life, making everyday activities such as walking and climbing stairs difficult or impossible. The disease can also lead to complications such as respiratory failure and lung cancer, which can be fatal. **Treatment Options** While there is currently no cure for pulmonary fibrosis, treatment options are available to manage symptoms and slow disease progression. These options may include: * Medications, such as pirfenidone and nintedanib * Oxygen therapy * Pulmonary rehabilitation * Lung transplantation INFOBOX: - Name: Pulmonary Fibrosis - Type: Chronic and progressive lung disease - Date: Late 19th century (first described) - Location: Worldwide - Known For: Scarring and thickening of lung tissue leading to impaired lung function and potentially life-threatening complications TAGS: Pulmonary fibrosis, lung disease, scarring, thickening, impaired lung function, shortness of breath, dry cough, feeling tired, weight loss, nail clubbing, pulmonary hypertension, respiratory failure, pneumothorax, lung cancer, high-resolution computed tomography, pulmonary function tests, pirfenidone, nintedanib, oxygen therapy, pulmonary rehabilitation, lung transplantation.
Health & MedicineConditions Encyclopedia Entry 1776544571
Cystic fibrosis (CF) is a chronic and progressive genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and potentially life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1776800524
Cystic fibrosis is a chronic, life-threatening genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and complications if left untreated.
Health & MedicineConditions Encyclopedia Entry 1779793744
Cystic fibrosis is a chronic, genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and early mortality if left untreated.
Health & MedicineConditions Encyclopedia Entry 1778052076
Cystic fibrosis is a **genetic disorder** that affects the **respiratory, digestive, and reproductive systems**, causing **persistent lung infections** and **malnutrition** due to **abnormal mucus production**.
Health & MedicineConditions Encyclopedia Entry 1778569805
Cystic fibrosis is a chronic, genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and early death if left untreated.